1. Inaugural “heckel Public Zoom Meeting”
Join us for the inaugural public Zoom meeting on heckel whole-body hyperthermia, open to all users and those interested in whole-body hyperthermia. This event marks the beginning of a series exploring various topics in the field.
10th of April, 2025, MEZ/CET: 16:00 – 17:15; UCT 15 – 16:15
Fever-range whole-body hyperthermia (FR-WBH) combined with oncological standard protocols – clinical experiences and scientific research
Program:
• Stefan Heckel-Reusser (heckel medizintechnik GmbH)
- Introduction
• Ass. Prof. Dr. Sebastian Zschaeck MD, radiation oncologist (Charité Berlin, Germany)
- Basic rationales for combining FR-WBH and standard treatment protocols (short summary)
- Published and running clinical studies on FR-WBH at Charité
• Dr. Joao Pinto MD, oncologist (Hospital da Luz, Lisboa, Portugal)
- Clinical experiences, selected case reports
• Spontaneous contributions of other heckel-HT3000 users
• Discussion
Don't miss this opportunity to engage with experts and advance your knowledge in FR-WBH.
2. ESIO Update 2025: Immunotherapy and integrative Oncology – Evidence and clinical practice – 3rd April 2025 in Zurich
This event organized by the European Society for Integrative Oncology (ESIO) organizes “will focus on immunotherapies in integrative oncology and therefore deals with the question of possible synergies, but also the potential risks of combining targeted immunotherapies with well established procedures from complementary medicine. Measures to strengthen the Immunosystem have a long tradition in integrative medicine. … In addition to an overview of the standards and predictive markers in immuno-oncology, the presentations will address, the potential of hyperthemia, plant extracts, but also the important role of psychoneuroimmunology. Last but not least an overview will be presented about the management of immunrelated toxicity.
3. Review on “Infrared radiation for cancer hyperthermia” by Ye et al. and corresponding Letter to the Editor by Lüchtenborg et al.
Whereas the use of wIRA in fever-range whole-body hyperthermia was comprehensively described in this review (based on an own study – look at heckelNews No 107), the thermography-controlled wIRA superficial hyperthermia was incomprehensibly not addressed as an oncological infrared application. Moreover, the authors corrected some basic physical definitions.
4. Oxygenation is an important but multifaceted radiosensitizing mechanism of combined hyperthermia / radiotherapy
They describe the differences of healthy and malignant breast tissue and conclude that “mild hyperthermia results in therapeutically relevant improvements of the oxygenation status of cancers and enhances mitochondrial ROS production, thus improving radiosensitivity.”
※본 게시물은 독일 heckel gmbH.에서 발행한 뉴스레터를 전달받아 발행한 것입니다.
